Investigating how sex differences affect brain cancer development and treatment outcomes
Project 1: Sex-specific developmental epigenetics in gliomagenesis
This study is looking at why glioblastoma, a tough type of brain cancer, affects men and women differently, hoping to find out how their genes might influence treatment responses so that doctors can create better, more personalized care for everyone.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cleveland Clinic Lerner Com-Cwru NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-10881797 on NIH RePORTER |
What this research studies
This research focuses on glioblastoma (GBM), a severe form of brain cancer that affects both males and females differently. The project aims to uncover the genetic and epigenetic factors that contribute to these differences in incidence and survival rates. By analyzing patient data, including imaging and genetic profiles, the researchers seek to understand why female patients tend to respond better to treatments compared to male patients. This knowledge could lead to more personalized and effective treatment strategies for GBM based on sex-specific biological mechanisms.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with glioblastoma, particularly those who are male or female and are seeking more effective treatment options.
Not a fit: Patients with glioblastoma who are not interested in participating in research or those with other unrelated health conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment options and outcomes for patients with glioblastoma by tailoring therapies based on sex-specific responses.
How similar studies have performed: Previous research has indicated that understanding sex differences in cancer biology can lead to significant advancements in treatment, suggesting that this approach has potential for success.
Where this research is happening
Cleveland, United States
- Cleveland Clinic Lerner Com-Cwru — Cleveland, United States (Active)
Researchers
- Principal investigator: Rubin, Joshua B — Cleveland Clinic Lerner Com-Cwru
- Study coordinator: Rubin, Joshua B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.